Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
Authors
Maria Isabel ManleyDr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

Contacts

Manley, Maria Isabel
合伙人律师
Boyle, Chris
合伙人律师

Capabilities

Suggested News & Insights

OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026
Global Life Sciences Update
盛德助力和誉医药与礼来公司达成19亿美元战略合作July 2, 2026
公告
盛德助力康缔亚（Caidya）与Simbec-Orion达成战略合并June 30, 2026
公告
Sidley Represents Bio-Techne in Its US$11.3 Billion Acquisition by Merck KGaAJune 25, 2026
公告
Don't Touch That Thermostat: Senate Examines Consumer Product Safety Commission Nominees Amid Agency OverhaulsJune 24, 2026
Product Liability Update
The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026
GoodLifeSci